These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 3921856
1. Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog. Caramona MM, Araújo D, Brandão F. Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):401-6. PubMed ID: 3921856 [Abstract] [Full Text] [Related]
2. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein. Caramona MM, Osswald W. Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855 [Abstract] [Full Text] [Related]
3. Deamination of released 3H-noradrenaline in the canine saphenous vein. Verbeuren TJ, Vanhoutte PM. Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):148-57. PubMed ID: 7063044 [Abstract] [Full Text] [Related]
4. Effects of a monoamine oxidase A inhibitor, FLA 668 (+) on the adrenergic mechanisms of the dog saphenous vein. Caramona MM, Esplugues JV, Osswald W. Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):181-5. PubMed ID: 2935741 [Abstract] [Full Text] [Related]
5. Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery. Branco D, Caramona M, Martel F, de Almeida JA, Osswald W. Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):286-93. PubMed ID: 1407015 [Abstract] [Full Text] [Related]
6. Release and disposition of 3H-noradrenaline in the saphenous vein of neonate and adult dogs. Moura D, Vaz-da-Silva MJ, Azevedo I, Brandão F, Guimarães S. Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):186-91. PubMed ID: 8474538 [Abstract] [Full Text] [Related]
7. On the mechanism of action of amezinium methylsulphate on the dog saphenous vein. Araújo D, Caramona MM, Osswald W. Eur J Pharmacol; 1983 Jun 03; 90(2-3):203-14. PubMed ID: 6873182 [Abstract] [Full Text] [Related]
8. The role of monoamine oxidase in the metabolism of exogenous noradrenaline by the human saphenous vein. Branco D, Caramona M, Araújo D, Osswald W. Fundam Clin Pharmacol; 1992 Jun 03; 6(3):145-52. PubMed ID: 1628876 [Abstract] [Full Text] [Related]
9. The role of MAO-A and MAO-B in the metabolic degradation of noradrenaline in human arteries. Figueiredo IV, Caramona M, Paiva MQ, Guimarães S. J Auton Pharmacol; 1998 Apr 03; 18(2):123-8. PubMed ID: 9730267 [Abstract] [Full Text] [Related]
10. Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog. Caramona MM. Naunyn Schmiedebergs Arch Pharmacol; 1982 May 03; 319(2):121-4. PubMed ID: 7110373 [Abstract] [Full Text] [Related]
12. A kinetic study of the release of noradrenaline by electrical stimulation: influence of presynaptic alpha-adrenoceptors. Brandão F, Davidson R, Monteiro JG. Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan 03; 328(3):248-52. PubMed ID: 2984584 [Abstract] [Full Text] [Related]
18. Differences in the metabolic fate of noradrenaline released by electrical stimulation or by tyramine. Brandão F, Monteiro JG, Osswald W. Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct 03; 305(1):37-40. PubMed ID: 723969 [Abstract] [Full Text] [Related]